Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, GPO Box 2471, Adelaide, SA, 5001, Australia.
Int J Clin Pharm. 2019 Oct;41(5):1341-1347. doi: 10.1007/s11096-019-00866-8. Epub 2019 Jun 25.
Background Internationally, antipsychotics are frequently initiated during hospital admission for older patients and use often continues post-discharge without indication. We located no Australian studies on this topic. Objective to identify the hospital admissions (excluding psychosis) associated with antipsychotic initiation and continuation in older Australians. Setting Australian Government Department of Veterans' Affairs. Method Retrospective analysis of administrative claims data for people admitted to hospital from 1 January 2014 to 31 December 2014, aged ≥ 65 years, who were antipsychotic naïve. Main outcome measure number of admissions associated with antipsychotic initiation, and the major diagnosis groups for these admissions. Where antipsychotics were initiated, we determined the time to cessation of antipsychotics after discharge. Results There were 142,009 hospital admissions for 66,415 people with a median age of 86 years. 921 (0.65%) admissions were associated with antipsychotic initiation, most commonly where the primary diagnoses were for mental and behavioural disorders excluding psychosis (17.8%) and injuries (16%). Fourteen percent of antipsychotic initiations were for primary diagnoses of delirium or dementia. When secondary diagnoses were considered, 55% of antipsychotic initiations were associated with delirium, dementia or both. The median duration of use among people who used antipsychotics was 132 days, and 40% continued use until death or one year follow-up. Conclusion Initiation of antipsychotics during hospital admissions was not frequent in this Australian population. Amongst those who did initiate antipsychotics, for almost half no diagnosis corresponding with an approved indication for use was recorded and long-term use of up to one year was common.
在国际上,抗精神病药经常在老年患者住院期间开始使用,并且在出院后常常继续使用而没有指征。我们没有找到关于这个主题的澳大利亚研究。目的:确定与澳大利亚老年人开始和继续使用抗精神病药相关的住院(不包括精神病)。地点:澳大利亚退伍军人事务部。方法:对 2014 年 1 月 1 日至 2014 年 12 月 31 日期间住院的年龄≥65 岁、抗精神病药初治的患者的行政索赔数据进行回顾性分析。主要结果:与抗精神病药开始使用相关的住院次数,以及这些住院的主要诊断类别。在开始使用抗精神病药的情况下,我们确定了出院后停止使用抗精神病药的时间。结果:共有 142009 例住院,涉及 66415 人,中位年龄为 86 岁。921 例(0.65%)住院与抗精神病药开始使用相关,最常见的主要诊断类别为精神和行为障碍(不包括精神病)(17.8%)和损伤(16%)。14%的抗精神病药开始用于治疗谵妄或痴呆的主要诊断。如果考虑次要诊断,55%的抗精神病药开始使用与谵妄、痴呆或两者有关。使用抗精神病药的人中,抗精神病药的使用中位数为 132 天,40%的人继续使用直至死亡或随访一年。结论:在澳大利亚人群中,住院期间开始使用抗精神病药并不常见。在开始使用抗精神病药的人群中,几乎有一半没有记录与批准的使用指征相对应的诊断,长期使用长达一年是很常见的。